Clinical trial
Evaluation Of Valaciclovir In Patients With Chickenpox
NCT00169416 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00169416 |
|---|---|
| Title | Evaluation Of Valaciclovir In Patients With Chickenpox |
| Official title | Clinical Evaluation of Valaciclovir Hydrochloride: 256U87 in Patients With Chickenpox - Open Uncontrolled Study. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Varicella |
| Intervention type | Drug |
| Interventions | valaciclovir HCl granules |
| Enrollment | 43 |
| Start date | Mar 1, 2005 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Sep 15, 2005 |
| Last update posted | Apr 15, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: